Life-Threatening Pustular and Erythrodermic Psoriasis Responding to Infliximab
June 2006 | Volume 5 | Issue 6 | Case Reports | 546 | Copyright © June 2006
Thomas G. Lewis MD, Chanisada Tuchinda MD, Henry W. Lim MD, Henry K. Wong MD PhD
AbstractPustular and erythrodermic psoriasis can be a debilitating and recalcitrant disease which may result in secondary complications such as sepsis, electrolyte imbalance, renal failure, and heart failure. We report a case of a 46-year-old patient with lifethreatening erythrodermic psoriasis who responded rapidly to intravenous infliximab.